Regulatory Pathway for Licensing Biotherapeutics in Mexico.
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Identity Profiling of Complex Mixtures of Peptide Products by Structural and Mass Mobility Orthogonal Analysis. VER MÁS
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Development of Functional Antibodies Directed to Human Dialyzable Leukocyte Extract (Transferon®). VER MÁS
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Determination of Peptide Profile Consistency and Safety of Collagen Hydrolysates as Quality Attributes. VER MÁS
-
UDIBI
admin_udibi3, , Sin categorizar, 0
The dialyzable leukocyte extract TransferonTM inhibits tumor growth and brain metastasis in a murine model of prostate cancer. VER...
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Sequencing Analysis and Identification of the Primary Peptide Component of the Dialyzable Leukocyte Extract “Transferon Oral”: The Starting Point...
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Determination of Peptide Profile Consistency and Safety of Collagen Hydrolysates as Quality Attributes. VER MÁS
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Development and validation of a bioassay to evaluate binding of adalimumab to cell membrane-anchored TNFα using flow cytometry detection....
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Fecha de publicación: 20 Septiembre 2019 Utilization of naproxen by Amycolatopsis sp. Poz 14 and detectionof the enzymes involved...